New insights contradict promising Alzheimer’s research

Approximately a year ago, Science published an article about bexarotene as a potential Alzheimer’s drug. The research group of Bart De Strooper (researcher at VIB and KU Leuven) in collaboration with the group of Rudi D’Hooge and scientists at JanssenPharmaceutica also tested this candidate drug. Their results were different, as were those of two American groups. Therefore, they recommend in a «technical comment» in Science that bexarotene should not be tested on patients.

Fuente : http://www.eurekalert.org/pub_releases/2013-05/vfi…



Hacer un comentario